Regine Bohacek received her PhD in physical chemistry from Rutgers University.  She received a post-doctoral fellowship from Ciba-Geigy in Summit, NJ.  Subsequently she became a permanent member of the computational chemistry group at Ciba-Geigy where she worked closely with synthetic chemists on a variety of structure based drug design projects.  To aid in these projects, she wrote a de novo design computer program called GrowMol.  More recently, she joined Ariad Pharmaceuticals in Cambridge, MA, as head of the computational chemistry group.  Presently, she has her own company, Boston De Novo Design, and has developed a second de novo program called AlleGrow and is consulting for a number of firms and universities.